LHC Group, Inc. LHCG
Set alert
At close · Feb 21
52-week range unavailable
- Open
- 169.16
- Prev close
- 169.81
- Mkt cap
- 5.29B
- Vol
- 1.28M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 169.16
- High
- 169.83
- Forward P/E
- 34.31
- Beta
- 0.42
- Short ratio
- 6.66
- Inst. own
- 89.45%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 22, 2023
- 50-d avg
- 163.15
- 200-d avg
- 163.38
- 1y target
- 173.33
2Y chart
Events in this range
- Nov 3, 2021Earnings: —; estimate 1.45; surprise —%
- Feb 23, 2022Earnings: —; estimate 1.32; surprise —%
- Mar 30, 2022Downgrade: Credit Suisse · Outperform → Neutral
- Mar 30, 2022Downgrade: Benchmark · Buy → Hold
- Mar 31, 2022Downgrade: Truist Securities · Buy → Hold
- Apr 4, 2022Downgrade: RBC Capital · Outperform → Sector Perform
- Apr 12, 2022Rating: Barclays · — → Equal-Weight
- Apr 25, 2022Downgrade: Deutsche Bank · Buy → Hold
- May 4, 2022Earnings: —; estimate 1.05; surprise —%
- Aug 3, 2022Earnings: —; estimate 1.32; surprise —%
- Nov 2, 2022Earnings: —; estimate 1.37; surprise —%
Signals (53)
| Name | Date | Ago |
|---|---|---|
| RSI: Overbought | Feb 17, 2023 | 3 years ago |
| SMA: Bullish | Feb 10, 2023 | 3 years ago |
| SMA: Bullish | Feb 10, 2023 | 3 years ago |
| MACD: Buy Signal | Feb 10, 2023 | 3 years ago |
| RSI: Oversold | Jan 27, 2023 | 3 years ago |
| MACD: Sell Signal | Jan 26, 2023 | 3 years ago |
| SMA: Bearish | Jan 24, 2023 | 3 years ago |
| SMA: Bearish | Jan 24, 2023 | 3 years ago |
| SMA: Bullish | Jan 20, 2023 | 3 years ago |
| SMA: Bearish | Jan 19, 2023 | 3 years ago |
| SMA: Bullish | Jan 18, 2023 | 3 years ago |
| SMA: Bullish | Jan 18, 2023 | 3 years ago |
| MACD: Buy Signal | Jan 9, 2023 | 3 years ago |
| RSI: Oversold | Jan 5, 2023 | 3 years ago |
| RSI: Oversold | Dec 27, 2022 | 3 years ago |
| SMA: Bearish | Dec 21, 2022 | 3 years ago |
| MACD: Sell Signal | Dec 19, 2022 | 3 years ago |
| MACD: Buy Signal | Dec 14, 2022 | 3 years ago |
| RSI: Oversold | Dec 1, 2022 | 3 years ago |
| SMA: Bearish | Nov 29, 2022 | 3 years ago |
| MACD: Sell Signal | Nov 28, 2022 | 3 years ago |
| MACD: Buy Signal | Nov 9, 2022 | 3 years ago |
| MACD: Sell Signal | Nov 3, 2022 | 3 years ago |
| MACD: Buy Signal | Oct 25, 2022 | 4 years ago |
| MACD: Sell Signal | Oct 20, 2022 | 4 years ago |
| MACD: Buy Signal | Oct 19, 2022 | 4 years ago |
| MACD: Sell Signal | Oct 12, 2022 | 4 years ago |
| MACD: Buy Signal | Sep 19, 2022 | 4 years ago |
| MACD: Sell Signal | Sep 16, 2022 | 4 years ago |
| MACD: Buy Signal | Sep 8, 2022 | 4 years ago |
| MACD: Sell Signal | Aug 15, 2022 | 4 years ago |
| MACD: Buy Signal | Aug 12, 2022 | 4 years ago |
| MACD: Sell Signal | Aug 8, 2022 | 4 years ago |
| SMA: Bullish | Jul 22, 2022 | 4 years ago |
| SMA: Bearish | Jul 18, 2022 | 4 years ago |
| SMA: Bullish | Jul 15, 2022 | 4 years ago |
| MACD: Buy Signal | Jul 7, 2022 | 4 years ago |
| RSI: Oversold | Jun 28, 2022 | 4 years ago |
| RSI: Oversold | Jun 16, 2022 | 4 years ago |
| SMA: Bearish | Jun 9, 2022 | 4 years ago |
| MACD: Sell Signal | Apr 11, 2022 | 4 years ago |
| RSI: Overbought | Apr 7, 2022 | 4 years ago |
| RSI: Overbought | Mar 29, 2022 | 4 years ago |
| MACD: Buy Signal | Mar 16, 2022 | 4 years ago |
| MACD: Sell Signal | Mar 14, 2022 | 4 years ago |
| SMA: Bullish | Feb 24, 2022 | 4 years ago |
| SMA: Bearish | Feb 17, 2022 | 4 years ago |
| SMA: Bullish | Feb 15, 2022 | 4 years ago |
| SMA: Bearish | Feb 10, 2022 | 4 years ago |
| SMA: Bullish | Feb 9, 2022 | 4 years ago |
| MACD: Buy Signal | Feb 1, 2022 | 4 years ago |
| MACD: Sell Signal | Jan 7, 2022 | 4 years ago |
| RSI: Oversold | Dec 1, 2021 | 4 years ago |
Key statistics
- Market cap
- 5.29B
- Enterprise value
- 6.23B
- Trailing P/E
- 82.83
- Forward P/E
- 34.31
- PEG ratio
- -22.34
- Price / sales
- 2.32
- Price / book
- 3.26
- EPS (TTM)
- 2.05
- Beta
- 0.42
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 1.75%
- Revenue (TTM)
- 2.28B
- Revenue growth
- -4.30%
- Free cash flow
- 35.70M
- Total cash
- 17.91M
- Total debt
- 843.96M
- Return on equity
- 3.57%
- Shares outstanding
- 31.15M
- Short % of float
- 12.36%
- 50-day average
- 163.15
- 200-day average
- 163.38
Analyst view
Consensus: hold
- Target (low)
- 170.00
- Target (mean)
- 173.33
- Target (high)
- 180.00
- Strong buy4
- Buy4
- Hold1
- Sell0
- Strong sell0
Next earnings
Feb 22, 2023
Expected Feb 22, 2023. Consensus EPS estimate 1.20.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 22, 2023 | Dec 1, 2022 | 1.17 | — | — | — |
| Nov 2, 2022 | Sep 1, 2022 | 1.37 | — | — | — |
| Aug 3, 2022 | Jun 1, 2022 | 1.32 | — | — | — |
| May 4, 2022 | Mar 1, 2022 | 1.05 | — | — | — |
| Feb 23, 2022 | Dec 1, 2021 | 1.32 | — | — | — |
| Nov 3, 2021 | Sep 1, 2021 | 1.45 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Apr 25, 2022 | Deutsche Bank | down | Buy | Hold |
| Apr 12, 2022 | Barclays | main | — | Equal-Weight |
| Apr 4, 2022 | RBC Capital | down | Outperform | Sector Perform |
| Mar 31, 2022 | Truist Securities | down | Buy | Hold |
| Mar 30, 2022 | Benchmark | down | Buy | Hold |
| Mar 30, 2022 | Credit Suisse | down | Outperform | Neutral |
About LHC Group, Inc.
LHC Group, Inc., a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. It operates through five segments: Home Health Services, Hospice Services, Home and Community-Based Services, Facility-Based Services, and Healthcare Innovations (HCI). The Home Health Services segment offers skilled nursing, medically oriented social services and physical, occupational, and speech therapy. The Hospice Services segment provides pain and symptom management accompanied by palliative medication, emotional and spiritual support, inpatient and respite care, homemaker services, dietary counseling, family bereavement counseling, and social worker visits. Its Home and Community-Based Services segment offers range of services, such as assistance with grooming, medication reminders, meal preparation, assistance with feeding, light housekeeping, respite care, transportation, and errand. The Facility-Based Services segment treats patients with severe medical conditions who require a high-level of care and frequent monitoring by physicians and other clinical personnel. This segment serves patients suffering from respiratory failure, neuromuscular and cardiac disorders, non-healing wounds, renal disorders, cancer, head and neck injuries, and mental disorders, as well as treats patients diagnosed with musculoskeletal impairments; and operates nursing facilities, family health center, rural health clinic, and physician practice, as well as offers physical therapy services. The HCI segment provides strategic health management services to accountable care organizations. The company was founded in 1994 and is based in Lafayette, Louisiana. As of February 22, 2023, LHC Group, Inc. operates as a subsidiary of OptumHealth, Inc..
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Country
- United States
- Website
- lhcgroup.com
News
- LHC Group: A Deal That Could Go Through Unchallenged After All
- Mergers and Acquisitions in 2023 Off To A Strong Start
- GDRX or LHCG: Which Is the Better Value Stock Right Now?
- LHC Group's (LHCG) Q3 Earnings & Revenues Miss Estimates
- LHC Group (LHCG) Q3 Earnings and Revenues Lag Estimates
- LHC Group announces third quarter 2022 financial results
- Earnings Scheduled For November 2, 2022
- LHC Group's (LHCG) Latest Tie-Up to Improve Patient Services
- LHC Group and University of Maryland Medical System announce home health partnership
- LHC Group to acquire home health provider in Georgia
Your note
Sign in to keep a note on LHCG — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| GACHASSIN NICHOLAS III | General Counsel | Stock Award(Grant) | Jan 30, 2023 | 15,860 |
| GOLDBERG JONATHAN D | Director | Stock Award(Grant) | Feb 28, 2022 | 57,472 |
| GREENSTEIN BRUCE D | Chief Technology Officer | Stock Award(Grant) | Jan 30, 2023 | 40,806 |
| HOLTZ CLIFFORD SCOTT | Director | Stock Award(Grant) | Feb 28, 2022 | 12,023 |
| MYERS KEITH G | Chief Executive Officer | Stock Award(Grant) | Jan 30, 2023 | 964,058 |
| NIXON RONALD THOMAS | Director | Stock Award(Grant) | Feb 28, 2022 | 27,100 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 14.91% | 4,625,841 | 785.51M | Dec 30, 2022 |
| Vanguard Group, Inc. (The) | 9.41% | 2,919,047 | 495.68M | Dec 30, 2022 |
| FIL LTD | 4.00% | 1,241,320 | 210.79M | Dec 30, 2022 |
| Alpine Associates Management Inc. | 3.25% | 1,009,370 | 171.40M | Dec 30, 2022 |
| State Street Corporation | 3.19% | 989,316 | 168.00M | Dec 30, 2022 |
| JP Morgan Chase & Company | 2.72% | 843,690 | 143.27M | Dec 30, 2022 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Core S&P Midcap ETF | 3.09% | 957,815 | 162.65M | Dec 30, 2022 |
| Vanguard Total Stock Market Index Fund | 2.81% | 872,618 | 148.18M | Sep 29, 2022 |
| Vanguard Small-Cap Index Fund | 2.41% | 748,354 | 127.08M | Sep 29, 2022 |
| iShares Russell 2000 ETF | 2.18% | 677,321 | 115.02M | Dec 30, 2022 |
| Merger Fund, The | 1.82% | 564,393 | 95.84M | Sep 29, 2022 |
| Vanguard Small-Cap Growth Index Fund | 1.39% | 432,553 | 73.45M | Sep 29, 2022 |